Aytu BioPharma, Inc.

8-K Terminated a material agreement Jun 25, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Modified rights of security holders Apr 2, 2026 10-Q Quarter ended 2025-12-31 Feb 3, 2026 8-K Results of operations (earnings release) Feb 3, 2026 8-K Regulation FD disclosure Jan 20, 2026 8-K Shareholder vote results Dec 10, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 10-K Fiscal year ended 2025-06-30 Sep 23, 2025 8-K Results of operations (earnings release) Sep 23, 2025 8-K Terminated a material agreement Aug 7, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Jun 23, 2025 8-K Regulation FD disclosure Jun 17, 2025 8-K Regulation FD disclosure; Other events Jun 9, 2025 8-K Entered a material agreement; Regulation FD disclosure Jun 6, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Jun 6, 2025 8-K Director or officer change; Shareholder vote results May 21, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-Q Quarter ended 2024-12-31 Feb 12, 2025 8-K Results of operations (earnings release) Feb 12, 2025 8-K Regulation FD disclosure Dec 4, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure; Other events Nov 13, 2024 8-K Regulation FD disclosure Oct 1, 2024 8-K Results of operations (earnings release) Sep 26, 2024 10-K Fiscal year ended 2024-06-30 Sep 26, 2024 8-K Regulation FD disclosure Aug 6, 2024 8-K Shareholder vote results Jun 26, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure; Other events Jun 18, 2024 8-K Results of operations (earnings release) May 15, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Results of operations (earnings release) Feb 14, 2024 10-Q Quarter ended 2023-12-31 Feb 14, 2024 8-K Entered a material agreement Nov 17, 2023 8-K Results of operations (earnings release) Nov 14, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Results of operations (earnings release) Oct 26, 2023